Description | Mediator of RNA polymerase II transcription subunit 12 (Fragment) |
Sequence | XERKKKSTKGKKRSQPATKTEDYGMGPGRSGPYGVTVPPDLLHHPNPGSITHLNYRQGSIGLYTQNQPLPAGGPRVDPYRPVRLPMQKLPTRPTYPGVLPTTMTGVMGLEPSSYKTSVYRQQQPAVPQGQRLRQQLQQSQGMLGQSSVHQMTPSSSYGLQTSQGYTPYVSHVGLQQHTGPADPTRHLQQRPSGYVHQQAPTYGHGLTSTQRFSHQTLQQTPMISTMTPMSAQGVQAGVRSTAILPEQQQQQ |
Length | 251 |
Position | Kinase |
Organism | Homo sapiens (Human) |
Kingdom | Metazoa |
Lineage | Eukaryota> Metazoa> Chordata> Craniata> Vertebrata> Euteleostomi> Mammalia> Eutheria> Euarchontoglires> Primates> Haplorrhini> Catarrhini> Hominidae> Homo. |
Aromaticity | 0.06 |
Grand average of hydropathy | -0.914 |
Instability index | 58.47 |
Isoelectric point | 10.30 |
Molecular weight | 27455.60 |
Publications | PubMed=15772651 PubMed=24129315 |
Annotated function |
|
GO - Cellular Component | mediator complex GO:0016592 IEA:InterPro |
GO - Biological Function | beta-catenin binding GO:0008013 IEA:InterPro |
GO - Biological Process |
Binary Interactions |
Repeats | >MDP29252 --------------------------------------------------------------------------- No. of Repeats|Total Score|Length |Diagonal| BW-From| BW-To| Level 3| 130.67| 36| 41| 79| 114| 1 --------------------------------------------------------------------------- 33- 64 (38.34/12.48) ..............Y....GVTVP..PDLLHH.PN.PGSIThlNYRQGSIGLYT 65- 111 (56.80/21.88) QNQplpaggprvdpYR...PVRLPM.QKLPTR.PTYPGVLP..TTMTGVMGLEP 112- 153 (35.53/11.05) SSY.......ktsvYRqqqPA.VPQgQRLRQQlQQSQGMLG..Q..SSVHQMTP --------------------------------------------------------------------------- --------------------------------------------------------------------------- No. of Repeats|Total Score|Length |Diagonal| BW-From| BW-To| Level 3| 101.11| 22| 73| 155| 176| 3 --------------------------------------------------------------------------- 155- 176 (40.38/20.43) SSY..........GLQTSQGYTPYVSHVGLQQ 192- 219 (25.44/10.21) SGYvhqqaptyghGLTSTQRF....SHQTLQQ 230- 251 (35.29/16.95) SAQ..........GVQAGVRSTAILPEQQQQQ --------------------------------------------------------------------------- |
Disease | breast cancer PMID:29157917 PMID:30230586 PMID:27438523 PMID:26452386 PMID:26601288 PMID:22913342 prostate cancer PMID:29157917 PMID:23836153 PMID:23661306 PMID:22610119 PMID:26924278 PMID:26383637 colon cancer PMID:23178117 PMID:29507187 renal cell carcinoma PMID:27050271 uterine tumors PMID:31520353 PMID:26383637 Uterine leiomyoma (ULM) PMID:33025089 PMID:23443020 PMID:30895261 endometrial polyps colorectal cancers PMID:24980722 phyllodes tumors PMID:25865354 PMID:30511242 extrauterine cancer PMID:25595892 uterine smooth muscle tumors PMID:28592321 colorectal cancers PMID:23132392 PMID:28183795 castration-resistant prostate cancer PMID:24938407 Breast fibroepithelial tumors PMID:26437033 fibroadenomas PMID:28513873 epithelial ovarian cancer PMID:29735544 Thyroid Cancer PMID:28634282 lung cancer PMID:28055980 renal cancer PMID:24504440 PMID:30895261 syndromic disorders Congenital heart disease PMID:30905399 cardiovascular diseases PMID:24751643 Alzheimer disease PMID:21293490 Fragile X syndrome PMID:31098807 uterine leiomyomas PMID:25615570 PMID:32094355 PMID:25106763 PMID:30619444 Blepharophimosis PMID:24715367 short humeri PMID:24715367 hirschsprung disease PMID:24715367 Goldberg-Shprintzen syndrome PMID:24715367 Opitz-Kaveggia syndrome PMID:24715367 breast fibroadenomas PMID:25106763 pelvic inflammatory disease PMID:28432313 |
MoRF Sequence | Start | Stop |
1) ILKRFA | 130 | 135 |
© 2021 Shailesh Lab
Designed by Dr. Shailesh Lab & Dr. Jitendra K. Thakur Lab